02385nam a2200481 i 4500 ocn968332603 OCoLC 20170210123720.0 m o d f cr bn||||a|||| 170113s2016 dcua ob f000 0 eng c GPO eng rda pn GPO GPO MvI pcc n-us--- KF31.5 .A3 2016a 1008-G (online) Y 1.1/5:114-429 Y 1.1/5:114-429 United States. Congress. Senate. Special Committee on Aging, author. Special report of the U.S. Senate Special Committee on Aging on the sudden price spikes in off-patent prescription drugs : the monopoly business model that harms patients, taxpayers, and the U.S. health system. Sudden price spikes in off-patent prescription drugs : the monopoly business model that harms patients, taxpayers, and the U.S. health system Washington : U.S. Government Publishing Office, 2016. 1 online resource (iii, 130 pages) : illustrations. text txt rdacontent computer c rdamedia online resource cr rdacarrier Report / 114th Congress, 2d session, Senate ; 114-429 Paper version available for sale by the Superintendent of Documents, United States Government Publishing Office. "February 11, 2016." CRDP Program record. Includes bibliographical references. Description based on online resource; title from PDF title screen (FDsys, viewed on Jan. 13, 2017). Prescription pricing United States. Drugs Prices United States. Generic drugs United States. Antitrust law United States. Competition United States. Consumer protection United States. Pharmaceutical industry Moral and ethical aspects United States. Legislative materials. lcgft Print version: United States. Congress. Senate. Special Committee on Aging. Special report of the U.S. Senate Special Committee on Aging on the sudden price spikes in off-patent prescription drugs (OCoLC)968332771 United States. Congress. Senate. Report ; 114-429. http://purl.fdlp.gov/GPO/gpo76062 257396 257396